b Tested in sodium chloride 0.9%.
c Test performed using the formulation WITHOUT edetate disodium.
d Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.
e Tested in Ringer’s injection, lactated.
f Lyophilized formulation tested.
g Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
h Concentration of fosphenytoin expressed in milligrams of phenytoin sodium equivalents (PE) per mL.
i Amoxicillin component. Amoxicillin in a 10:1 fixed-ratio concentration with clavulanic acid.
j Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
k Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.
l Not specified whether concentration refers to single component or combined components.
m Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
n Tested in both dextrose 5% and sodium chloride 0.9%.
o Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
p Test performed using the formulation WITH edetate disodium.
q Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.